MM

Minoshi Maheshwari

Active Director Director DIN 01575975
DIN 01575975 First appointment Jan 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jan 2003
Shareholding value •••• Premium profile

About Minoshi Maheshwari

Data last updated:

Minoshi Maheshwari is a Director at Balaxi Pharmaceuticals Limited (since 2017), Director at Balaxi Overseas Private Limited (since 2003) and Director at Balaxi Capital Holdings Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹527 Cr; the largest is Balaxi Pharmaceuticals Limited at ₹289 Cr (FY 2025). Earlier, Minoshi Maheshwari was a Director at Lobito Mobitech Private Limited (from 2010) and Designated Partner at Balaxi Properties Llp (from 2016).

DIN 01575975
Primary Designation Director
Industry Pharma
First Appointment 30 Jan 2003
Oldest Company Age 84 yrs
Largest company Balaxi Pharmaceuticals Limited · ₹289 Cr (FY 2025)
Combined revenue ₹527 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Balaxi Pharmaceuticals Limited L25191TG1942PLC121598
Director04 May 20171942₹289 Cr (FY 2025)Active
Balaxi Overseas Private Limited U51909TG2003PTC040399
Director30 Jan 20032003₹239 Cr (FY 2024)Active
Director04 Jan 20232023Active
Designated Partner04 Feb 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lobito Mobitech Private Limited U32204TG2010PTC070087
Director20 Aug 20102010Strike Off
Designated Partner13 May 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Balaxi Pharmaceuticals Limited
Lobito Mobitech Private Limited
Balaxi Overseas Private Limited
Balaxi Properties Llp
Premium access

Shareholding and investment profile for Minoshi Maheshwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Minoshi Maheshwari

Minoshi Maheshwari currently holds 4 directorships: Balaxi Pharmaceuticals Limited (Director, since 04 May 2017, revenue ₹289 Cr (FY 2025)); Balaxi Overseas Private Limited (Director, since 30 Jan 2003, revenue ₹239 Cr (FY 2024)); Balaxi Capital Holdings Private Limited (Director, since 04 Jan 2023); Balaxi Holdings Llp (Designated Partner, since 04 Feb 2016).

Minoshi Maheshwari was first appointed on 30 Jan 2003 as Director at Balaxi Overseas Private Limited. The most recent appointment on record is 04 Jan 2023 at Balaxi Capital Holdings Private Limited.

The 2 current companies of Minoshi Maheshwari that report revenue have a combined latest revenue of ₹527 Cr: Balaxi Pharmaceuticals Limited ₹289 Cr (FY 2025); Balaxi Overseas Private Limited ₹239 Cr (FY 2024).

Minoshi Maheshwari held 2 earlier board appointments: Lobito Mobitech Private Limited (Director, from 20 Aug 2010); Balaxi Properties Llp (Designated Partner, from 13 May 2016).

The current boards of Minoshi Maheshwari's companies include Akshita Surana (Balaxi Pharmaceuticals Limited), Aman Purohit (Balaxi Pharmaceuticals Limited), Amol Anand Mantri (Balaxi Pharmaceuticals Limited), Ashish Maheshwari (Balaxi Pharmaceuticals Limited), Gandhi Gamji (Balaxi Pharmaceuticals Limited), Kunal Mahendra Bhakta (Balaxi Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available